Table 1.

Percentage of Gel Contraction in SMCs at 12 Hours

Cell Type	-deta/NO	+deta/NO	+deta/NO +Rp-8-pCPT-cGMPS (50μM)
wt-VASP	84 ± 5 %	56 ± 5 % #	77 ± 7 % ≠
LXSN	86 ± 3 %	85 ±4 %	86 ± 4 %
S239A-VASP	82 ± 3 %	80 ± 6 %	79 ± 4 %
S239D-VASP	64 ± 3 % *	63 ± 5 %	60 ± 5 %

^*P ≤ 0.02 S239D-VASP vs. other cell types.

^#P ≤ 0.03 deta/NO-treated wt-VASP vs. wt-VASP without deta/NO.

^≠P ≤ 0.04 deta/NO-treated wt-VASP in the presence of Rp-8-pCPT-cGMPS vs. deta/NO-treated wt-VASP without Rp-8-pCPT-cGMPS.